Disclaimer: All content on this site — including company research, ratings, price targets, and market commentary — is generated automatically by artificial intelligence and may or may not have been reviewed, fact-checked, or verified by any human analyst, editor, or financial professional. No representation or warranty, express or implied, is made as to the accuracy, completeness, timeliness, or reliability of any information presented. StockWatch.report and its operators accept no responsibility or liability whatsoever for any loss or damage arising from reliance on this content. Nothing on this site constitutes investment, financial, legal, or tax advice, or a recommendation or solicitation to buy or sell any security. This content is provided for informational purposes only and must not be used as the basis for any investment decision. The operators of StockWatch.report and their affiliates may hold long or short positions in securities discussed on this site at any time. You are solely responsible for your own investment decisions and should consult a qualified, licensed financial professional before acting on any information presented here. Use of this site is governed by, and subject to, our Terms and Conditions.
PII Polaris Inc.PII: Polaris Reports Q1 FY2026 Operating Loss as Revenue Reaches $1.54 Billion
27 Oct 2026, 9:41 AM ETCLS Celestica, Inc.CLS: Celestica Reports Q3 FY2026 Results With $8.74B Revenue and $565M Net Income
27 Oct 2026, 9:41 AM ETRCL Royal Caribbean Cruises Ltd.RCL: Royal Caribbean Posts $1.94B Net Income and $8.54B Revenue in Q2 2026
27 Oct 2026, 9:41 AM ETSOFI SoFi Technologies, Inc.SOFI: SoFi Technologies Posts $168M Net Income and $0.14 Diluted EPS in Q2 FY2026
27 Oct 2026, 9:41 AM ETHRI Herc Holdings Inc.HRI: Herc Holdings Discloses Executive Departure Alongside Q3 Net Loss of $18 Million
27 Oct 2026, 9:39 AM ETHWKN Hawkins, Inc.HWKN: Hawkins Reports Q2 FY2027 Results — Revenue Hits $573.7M, Shares Surge 14.7%
27 Oct 2026, 9:39 AM ETKNSA Kiniksa Pharmaceuticals InternaKNSA: Kiniksa Pharmaceuticals Reports Q1 FY2026 Profitability on $137.8M in Revenue
27 Oct 2026, 9:39 AM ETWULF TeraWulf Inc.WULF: TeraWulf Discloses New Material Agreement and Debt Obligation in 8-K Filing
26 Oct 2026, 11:12 AM ETSGRY Surgery Partners, Inc.SGRY: Surgery Partners Reports Q2 2026 Results — Operating Income of $173.6M Drives Shares Up ~46%
26 Oct 2026, 10:11 AM ET